eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Meda Pharmaceuticals

Sky Way House, Parsonage Road, Takeley, Bishop's Stortford, CM22 6PU
Telephone: 0845 460 0000
Fax: 0845 460 0002
Medical Information Direct Line: +44 (0)1748 828 810
Medical Information e-mail: meda@professionalinformation.co.uk
Medical Information Fax: +44 (0)1748 828 801
Out of Hours contact: +44 (0)1748 828 810

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Summary of Product Characteristics last updated on the eMC: 31/03/2010
SPC Tambocor 100mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 31/03/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 10 date of revision of the text
Updated on 13/03/2008 and displayed until 31/03/2010
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 10 date of revision of the text
Updated on 22/08/2006 and displayed until 13/03/2008
Reasons for adding or updating:
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
Updated on 24/11/2003 and displayed until 22/08/2006
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic Indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
Updated on 15/01/2003 and displayed until 24/11/2003
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 18/11/2002 and displayed until 15/01/2003
Reasons for adding or updating:
  • Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
Updated on 28/11/2001 and displayed until 18/11/2002
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 12/11/2001 and displayed until 28/11/2001
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Updated on 15/08/2001 and displayed until 12/11/2001
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 15/08/2001 and displayed until 15/08/2001
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 15/08/2001 and displayed until 15/08/2001
Reasons for adding or updating:
  • Change to section 9 - Date of Renewal of Authorisation
  • Correction of spelling/typing errors
Updated on 11/07/2001 and displayed until 15/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 27/02/2001 and displayed until 11/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 22/11/2000 and displayed until 27/02/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 22/11/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  flecainide acetate